A Study to Investigate the Effect of GDC-0449 on the QT/QTc Interval in Healthy Female Subjects

NCT01173536 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: GDC-0449
DRUG: moxifloxacin
DRUG: placebo

Sponsor

Genentech, Inc.